In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

.

Source: Expert Opinion on Biological Therapy - December 28, 2019 Category: Drugs & Pharmacology Authors: Marco Galluzzo Simone D ’Adamio Dionisio Silvaggio Paolo Lombardo Luca Bianchi Marina Talamonti Source Type: research